These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26506141)

  • 1. Crystallization of undercooled liquid fenofibrate.
    Amstad E; Spaepen F; Weitz DA
    Phys Chem Chem Phys; 2015 Nov; 17(44):30158-61. PubMed ID: 26506141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the effect of moisture protection on solid-state stability and dissolution of fenofibrate and ketoconazole solid dispersions using PXRD, HSDSC and Raman microscopy.
    Kanaujia P; Lau G; Ng WK; Widjaja E; Schreyer M; Hanefeld A; Fischbach M; Saal C; Maio M; Tan RB
    Drug Dev Ind Pharm; 2011 Sep; 37(9):1026-35. PubMed ID: 21417604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and in vitro/in vivo evaluation of fenofibrate nanocrystals.
    Zuo B; Sun Y; Li H; Liu X; Zhai Y; Sun J; He Z
    Int J Pharm; 2013 Oct; 455(1-2):267-75. PubMed ID: 23876497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fabrication of fenofibrate nanocrystals by probe sonication method for enhancement of dissolution rate and oral bioavailability.
    Ige PP; Baria RK; Gattani SG
    Colloids Surf B Biointerfaces; 2013 Aug; 108():366-73. PubMed ID: 23602990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled crystallization of the lipophilic drug fenofibrate during freeze-drying: elucidation of the mechanism by in-line Raman spectroscopy.
    de Waard H; De Beer T; Hinrichs WL; Vervaet C; Remon JP; Frijlink HW
    AAPS J; 2010 Dec; 12(4):569-75. PubMed ID: 20625865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
    Hu J; Ng WK; Dong Y; Shen S; Tan RB
    Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved dissolution rate and bioavailability of fenofibrate pellets prepared by wet-milled-drug layering.
    Wang P; Luo Q; Miao Y; Ying L; He H; Cai C; Tang X
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1344-53. PubMed ID: 22283480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate.
    Jia Z; Lin P; Xiang Y; Wang X; Wang J; Zhang X; Zhang Q
    Eur J Pharm Biopharm; 2011 Sep; 79(1):126-34. PubMed ID: 21658449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of lipid matrix particles for fenofibrate: effect of polymorphism of glycerol monostearate on drug incorporation and release.
    Xia D; Cui F; Gan Y; Mu H; Yang M
    J Pharm Sci; 2014 Feb; 103(2):697-705. PubMed ID: 24375427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and delivery of improved amorphous fenofibrate solid dispersions prepared by thin film freezing.
    Zhang M; Li H; Lang B; O'Donnell K; Zhang H; Wang Z; Dong Y; Wu C; Williams RO
    Eur J Pharm Biopharm; 2012 Nov; 82(3):534-44. PubMed ID: 22974985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of excipient, solvent and packaging to optimize the performance of spray-dried formulations: case example fenofibrate.
    Hugo M; Kunath K; Dressman J
    Drug Dev Ind Pharm; 2013 Feb; 39(2):402-12. PubMed ID: 22591213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sericin/Poly(ethylcyanoacrylate) Nanospheres by Interfacial Polymerization for Enhanced Bioefficacy of Fenofibrate: In Vitro and In Vivo Studies.
    Parisi OI; Fiorillo M; Scrivano L; Sinicropi MS; Dolce V; Iacopetta D; Puoci F; Cappello AR
    Biomacromolecules; 2015 Oct; 16(10):3126-33. PubMed ID: 26348208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of fenofibrate microemulsion for improved bioavailability.
    Hu L; Wu H; Niu F; Yan C; Yang X; Jia Y
    Int J Pharm; 2011 Nov; 420(2):251-5. PubMed ID: 21907776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of fenofibrate immediate-release tablets involving wet grinding for improved bioavailability.
    Zhang L; Chai G; Zeng X; He H; Xu H; Tang X
    Drug Dev Ind Pharm; 2010 Sep; 36(9):1054-63. PubMed ID: 20818965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extraordinary Long-Term-Stability in Kinetically Stabilized Amorphous Solid Dispersions of Fenofibrate.
    Theil F; Milsmann J; Kyeremateng SO; Anantharaman S; Rosenberg J; van Lishaut H
    Mol Pharm; 2017 Dec; 14(12):4636-4647. PubMed ID: 29111751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of a hot-melt granulation process to enhance fenofibrate solid dose manufacturing.
    Chaudhary RS; Amankwaa E; Kumar S; Hu T; Chan M; Sanghvi P
    Drug Dev Ind Pharm; 2016; 42(7):1137-48. PubMed ID: 26552938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impregnation of Fenofibrate on mesoporous silica using supercritical carbon dioxide.
    Bouledjouidja A; Masmoudi Y; Van Speybroeck M; Schueller L; Badens E
    Int J Pharm; 2016 Feb; 499(1-2):1-9. PubMed ID: 26732521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro and in vivo evaluation of fenofibrate with a self- microemulsifying formulation.
    Xiumin LI; Man GE; Minzi LU; Yinghua J; Dongqin Q
    Curr Drug Deliv; 2015; 12(3):308-13. PubMed ID: 26054534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo evaluation of a self-microemulsifying drug delivery system for the poorly soluble drug fenofibrate.
    Cho YD; Park YJ
    Arch Pharm Res; 2014 Feb; 37(2):193-203. PubMed ID: 23754165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of a fenofibrate-hydroxypropyl-beta-cyclodextrin system prepared by a co-grinding method.
    Gu FG; Wang Y; Meng GD; Han HB; Wu CZ
    Pharmazie; 2012 Feb; 67(2):143-6. PubMed ID: 22512084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.